Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New wrinkle treatment shows promise in clinical trial

NCT ID NCT04821089

First seen Nov 01, 2025 · Last updated May 25, 2026 · Updated 27 times

Summary

This study is testing a new medication called IPN10200 to see if it can safely improve the appearance of moderate to severe frown lines, forehead lines, and crow's feet in adults. About 727 participants will receive different doses of the drug or a placebo to find the best dose. The goal is to reduce wrinkle severity as judged by both doctors and participants.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MODERATE TO SEVERE UPPER FACIAL LINES are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Aimed S.A.S

    Lyon, France

  • CRS Clinical Research Services Berlin GMBH

    Berlin, 13353, Germany

  • Clinique de Chirurgie Esthétique Iéna

    Paris, France

  • Dermatologische Gemeinschaftspraxis Blankenfelde-Mahlow

    Mahlow, Germany

  • Fachbereich Chemie Institut für Biologie und Molekularbiologie Studiengang Kosmetikwissenschaft

    Hamburg, Germany

  • Interdisciplinary Study Association

    Kassel, State of Berlin, Germany

  • Interdisciplinary Study Association

    Berlin, Germany

  • MEDITI - Clinique Del Mar

    Antibes, France

  • Privatpraxis Dr. Hilton & Partner

    Düsseldorf, Germany

  • ROSENPARK RESEARCH GmbH

    Darmstadt, Germany

Conditions

Explore the condition pages connected to this study.